Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

UNC13A Gene Brings New Hope for ALS Disease-Modifying Drugs.

Neuroscience bulletin - 1 Nov 2022

Chen Xi, Chu Heling, Dong Yi

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis
Share to Genetic Predisposition to Disease
Share to Polymorphism, Single Nucleotide

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Open in PubMed Open full text

Identifiers

PMID: 35907106
DOI: 10.1007/s12264-022-00924-8
PMCID: PMC9672290

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

UNC13A Gene Brings New Hope for ALS Disease-Modifying Drugs.PMID 35907106Read ↗

UNC13A in amyotrophic lateral sclerosis: from genetic association to therapeutic targetSemantic proximity Read ↗

Finding a Treatment for ALS - Will Gene Editing Cut It?Semantic proximity Read ↗

Gene therapy breakthroughs in ALS: a beacon of hope for 20% of ALS patientsSemantic proximity Read ↗

ALS Genetics: Gains, Losses, and Implications for Future TherapiesSemantic proximity Read ↗

Development of Therapeutics for C9ORF72 ALS/FTD-Related DisordersSemantic proximity Read ↗

UNC13A is a modifier of survival in amyotrophic lateral sclerosis.Semantic proximity Read ↗

OPTN variants in ALS cases: a case report of a novel mutation and literature review.Semantic proximity Read ↗

CRISPR-mediated gene correction links the ATP7A M1311V mutations with amyotrophic lateral sclerosis pathogenesis in one individual.Semantic proximity Read ↗

ASO therapy for C9ORF72-related ALS/FTD.Semantic proximity Read ↗

From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to TranslationSemantic proximity Read ↗

NUB1 snubs huntingtin toxicity.Semantic proximity Read ↗

Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.